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Abstract
Mutable collagenous tissues (MCTs) of echinoderms show reversible changes in tensile properties (mutability) that are
initiated and modulated by the nervous system via the activities of cells known as juxtaligamental cells. The molecular
mechanism underpinning this mechanical adaptability has still to be elucidated. Adaptable connective tissues are also
present in mammals, most notably in the uterine cervix, in which changes in stiffness result partly from changes in the
balance between matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs). There have been no
attempts to assess the potential involvement of MMPs in the echinoderm mutability phenomenon, apart from studies
dealing with a process whose relationship to the latter is uncertain. In this investigation we used the compass depressor
ligaments (CDLs) of the sea-urchin Paracentrotus lividus. The effect of a synthetic MMP inhibitor - galardin - on the
biomechanical properties of CDLs in different mechanical states (‘‘standard’’, ‘‘compliant’’ and ‘‘stiff’’) was evaluated by
dynamic mechanical analysis, and the presence of MMPs in normal and galardin-treated CDLs was determined semi-
quantitatively by gelatin zymography. Galardin reversibly increased the stiffness and storage modulus of CDLs in all three
states, although its effect was significantly lower in stiff than in standard or compliant CDLs. Gelatin zymography revealed a
progressive increase in total gelatinolytic activity between the compliant, standard and stiff states, which was possibly due
primarily to higher molecular weight components resulting from the inhibition and degradation of MMPs. Galardin caused
no change in the gelatinolytic activity of stiff CDLs, a pronounced and statistically significant reduction in that of standard
CDLs, and a pronounced, but not statistically significant, reduction in that of compliant CDLs. Our results provide evidence
that MMPs may contribute to the variable tensility of the CDLs, in the light of which we provide an updated hypothesis for
the regulatory mechanism controlling MCT mutability.
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Introduction
Echinoderms (starfish, sea urchins and others) have connec-
tive tissues with the unique ability to change mechanical
properties such as elasticity and viscosity in short physiological
time scales (,1 s to minutes) under nervous control [1,2]. They
are called either mutable collagenous tissues (MCTs) to reflect
the reversibility of their tensile changes, or catch connective
tissues due to their energy-sparing capacity to maintain body or
appendage posture with low oxygen consumption [1–4]. Each
shows one of three patterns of tensile change: (1) only reversible
stiffening and destiffening (e.g. sea urchin peristomial membrane
and compass depressor ligament) [5,6]; (2) only irreversible
destabilization, always associated with autotomy (defensive self-
detachment) e.g. crinoid syzygial ligament [7]; (3) irreversible
destabilization as well as reversible stiffening and destiffening
(e.g. ophiuroid intervertebral ligament) [8]. MCTs are present
in all five living echinoderm classes in several anatomical forms
(dermal connective tissue, interossicular ligaments and tendons).
Most MCT structures resemble mammalian connective tissues
in that they consist largely of collagen fibril arrays, proteogly-
cans (PGs), fibrillin-containing microfibrils and water [2,9–17].
MCTs are also characterized by the invariable presence of
specialized neurosecretory-like cells known as juxtaligamental
cells (JLCs) [2,18]. There is evidence that the intracellular
granules of JLCs store molecules that directly affect the
interfibrillar cohesion of MCTs [2]. So far, only one such
potential effector molecule has been identified and fully
characterized. This is tensilin, a glycoprotein present in the
dermis of holothurians (sea cucumbers) that forms interfibrillar
bridges between collagen fibrils, preventing interfibrillar slippage
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and increasing the resistance of the tissue to tensile forces
[19,20]. Tensilin and another incompletely characterized
molecule from holothurian dermis [21] may be regulatory
stiffening agents. So far, no potential regulatory destiffening
agents have been identified. It has been speculated that certain
enzymes might have such a role. For example, since the C-
terminus of tensilin, which contains a collagen-binding domain,
is susceptible to proteolysis, it has been suggested that rapid
destiffening of holothurian dermis could depend on the
inactivation of tensilin by a specific protease [19]. The fact
that the amino acid sequence of tensilin indicates 21–36%
homology with mammalian tissue inhibitors of metalloprotei-
nases (TIMPs) [19], raises the intriguing possibility that matrix
metalloproteinases (MMPs) may be directly involved or that the
regulatory mechanism has evolved from a MMP-TIMP system
[2].
MMPs are a family of enzymes that can degrade all
extracellular matrix (ECM) components and are extensively
involved in the ECM remodelling that accompanies morpho-
genesis and wound healing in mammals [22–25], and develop-
ment and regeneration in echinoderms [26–28]. Furthermore,
MMPs contribute to the destiffening of the mammalian uterine
cervix, which precedes and facilitates the dilatation of the cervix
during fetal delivery [29–35]. Whilst the uterine cervix can also
be regarded as a mutable collagenous structure, its changes in
mechanical properties differ from those of echinoderm MCTs in
having a much longer time course (hours to weeks) and in being
under primarily endocrine rather than neural control [34].
Another important difference is that cervical destiffening is
achieved partly through the degradation of collagen fibrils
[30,34,35], whereas there is no evidence that this accompanies
the destiffening of echinoderm MCTs and indeed the capacity
of most of these tissues to rapidly restiffen makes this highly
unlikely a priori [2,36]. MMPs could, however, destabilize
echinoderm MCTs by hydrolyzing non-collagenous components
that contribute to interfibrillar cohesion. Such a mechanism
may be responsible for the dermal liquefaction shown by some
holothurians, which appears to result from the digestion of
interfibrillar molecules (possibly proteoglycans) by a gelatinolytic
enzyme that has no discernible effect on the collagen fibrils
themselves [37].
Dermal liquefaction is an extreme (or even fatal) phenomenon
whose relationship to reversible MCT mutability is unclear
[37,38]. We chose to explore the possible role of MMPs in the
latter by using as a model a more conventional mutable
collagenous structure – the compass depressor ligament (CDL)
from the lantern (masticatory apparatus) of the sea urchin
Paracentrotus lividus (Lam.). The sea urchin lantern contains ten
CDLs, which, when stiff, help to stabilize the position of the
lantern, and which destiffen to permit movement of the lantern by
its intrinsic musculature [5]. We examined the effect of a broad-
spectrum MMP inhibitor on the mechanical properties of CDLs in
different tensile states and we used gelatin zymography to quantify
MMPs in such CDLs. Our results provide evidence that MMPs
may contribute to the variable tensility of the CDL, in the light of
which we provide an updated hypothesis for the regulatory
mechanism underpinning MCT mutability. It is proposed that in
all mechanical states both activated MMPs and crosslink
components are produced constitutively at a constant rate, and
that the degree of interfibrillar crosslinking, and therefore stiffness,
is regulated through changes in the rate of release of an
endogenous MMP inhibitor.
Materials and Methods
Animal Tissues and Bathing Solutions
Adult individuals of P. lividus of similar size were collected in
Aguda (north Portuguese coast) and maintained in an aquarium as
described previously [36]. Isolated preparations of compass
depressor ligaments (CDLs) were obtained from the lantern and
mutability was mimicked as described previously [36]. In brief, the
‘compliant’ state was reproduced in vitro by immersing isolated
CDLs for 45 minutes in 0.1% propylene phenoxetol (Sigma
Aldrich 484423) in seawater (PPSW), which is an effective
anaesthetic for echinoderms. The ‘stiff’ state was obtained by
immersion of CDLs in 1 mM acetylcholine chloride (Sigma
Aldrich 6625) in seawater (AChSW) for 15 min. Controls, which
were in the ‘standard’ state, were kept in seawater (SW) alone.
Although the CDL is partly delimited by a contractile myoepi-
thelium, in P. lividus this occupies only around 8% of its total cross-
sectional area, and we have shown previously that destiffening and
stiffening due to PPSW and AChSW respectively result from
changes in the passive mechanical properties of the collagenous
component and not from effects on the myoepithelium (Wilkie,
Fassini and Candia Carnevali, in preparation) [5].
Mechanical Properties
Dynamic mechanical tests. CDLs, which are strap-shaped
bands of soft tissue 9–10 mm long, 0.2–0.4 mm wide and less than
0.1 mm thick, were dissected intact together with a small portion
of the skeletal ossicles to which they were attached at both ends
(Fig.1). The presence of the ossicle portions enabled the CDLs to
be held firmly in the dynamic mechanical apparatus with minimal
damage to the soft tissue. Fresh CDLs were always used and,
before being analysed, were stored in SW. All CDLs were tested at
a constant temperature of 20uC.
A dynamic mechanical analyser (DMA) (Tritec 2000; Triton
Technology Ltd., Nottinghamshire, UK) with tension clamping
geometry was used to determine the effect of chemical
stimulation on the biomechanical properties of the CDL.
Standard tension tests were chosen, because in the animal
CDLs are continuously stretched due to routine movements of
the lantern. The ossicles at the ends of each CDL were glued to
the clamps of the equipment with cyanoacrylate glue, which was
found to be suitable because of its rapid polymerization time (a
few seconds). Beeswax (Sigma-Fluka 14367) was used as a
coating, in order to avoid contact between the cyanoacrylate
Figure 1. Schematic representation of the CDL dissection.
doi:10.1371/journal.pone.0049016.g001
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glue and testing solutions. The mean thickness of each CDL
was determined by several measurements using a digital
micrometer, and it was assumed that sample cross-section was
circular (average diameter between 0.2–0.4 mm). After mechan-
ical fixation, and before starting the mechanical tests, tissues
were allowed to equilibrate for 10 min in seawater. During the
experiments, sinusoidal force and displacement signals were
measured simultaneously and this data set was resolved into
complex modulus (E*), which is a measure of stiffness, and tan
d (damping), which is the ratio of the loss modulus (E99) to the
storage modulus (E). The storage modulus represents the elastic
modulus in phase with the stress, while the loss modulus
represents the viscous contribution to stiffness because it is an
out-of-phase component. As the software provided E9, E99 and





Viscoelasticity of CDLs in different mechanical
states. CDLs were clamped and left in seawater for 10 min
before being treated with propylene phenoxetol or acetylcholine,
as described above, to reproduce the compliant and stiff states,
respectively. Five animals, and at least three CDLs from each
animal were used for each mechanical state. To determine the
optimal experimental parameters, i.e. those that provided maxi-
mum differentiation between the three mechanical states, CDLs in
all three conditions were subjected to two types of experiment: (1)
In constant frequency experiments, the frequency was kept at
1 Hz and each CDL was subjected to a maximum strain which
was changed stepwise in the following sequence: 5%, 10%, 15%,
10% and 5%, over the course of 5 sec (15% strain causes the
rupture of some CDLs). (2) In constant strain tests, the maximum
imposed strain was kept at 13% and each CDL was subjected to a
frequency that changed stepwise as follows: 0.1 Hz, 0.3 Hz,
0.5 Hz, 0.7 Hz 1 Hz, 3 Hz, 5 Hz.
Effect of MMP inhibition on CDL viscoelasticity. The
effect of the MMP inhibitor galardin (Calbiochem 364205) at 25
and 50 mM was investigated in CDLs using dynamic mechanical
tests at 1 Hz and 13% maximum strain (the conditions that
provide the maximum differentiation between the different
mechanical states). Untreated CDLs were tested for 4 min before
galardin was added. The duration of galardin inhibition was
quantified as the time period between the point at which the E*
maximized after addition of 50 mM galardin, and the point at
which the E* returned to the value observed immediately before
galardin addition. The effect of galardin on E* was quantified by
normalizing the E* value when it started to decrease against the
value just before the application of the chemical. The reversibility
of the galardin effect was tested by immersing CDLs in the three
mechanical states in SW, AChSW or PPSW containing 50 mM
galardin, then rinsing the CDLs with SW, AChSW or PPSW alone
and treating them again with 50 mM galardin in the respective
solutions.
Enzymatic Activity
Gelatinolytic activity in CDLs. Gelatinolytic activity was
detected in more than five animals for each of the three
mechanical states. Animals, from which the top half of the test
(skeleton) had been removed to expose the intact lantern, were
incubated in SW, AChSW and PPSW to obtain ligaments in
the standard, stiff and compliant states, respectively. The CDLs
were then quickly excised and placed in ice-cold RIPA lysis
buffer (200 mMTris-HCl buffer pH 7.5 in 1% Triton-X 100,
150 mMNaCl and 1% of NP-40), homogenized, and sonicated
for 30 min at 4uC to release associated MMPs. After sonication,
proteins were precipitated with acetone by overnight incubation
at 220uC. Extracts were then centrifuged at 14000 rpm for
10 min at 4uC and supernatants were collected. Protein
precipitates were then diluted in PBS and the protein
concentration of the samples was determined using a DC
Protein Assay kit from Bio-Rad (500–0112). For each sample,
15 mg of protein was applied to non-reduced SDS-polyacryl-
amide gel electrophoresis using 10% gels containing 0.1%
gelatin (bovine skin, Type B, SIGMA, G9391). The gels were
electrophoresed under 80 V with a maximum intensity current
of 120 mA, in a Mini-PROTEANH Tetra Cell system from Bio-
Rad. Following electrophoresis, the gel was washed twice with
2% v/v Triton X-100, to remove excess SDS, and incubated
with MMP substrate buffer (50 mMTris–HCl, pH 7.5,
10 mM CaCl2) for 16 h. After incubation, the gel was washed
with distilled water and stained with 0.1% w/v Coomassie
Brilliant Blue solution (Sigma R-250). Areas of proteolysis
appeared as clear bands against a blue background of gelatin
substrate. Molecular mass determinations were made with
reference to pre-stained protein standards. Stained gels were
scanned and band densities were quantified by densitometric
analysis (Quantity One Software, Bio-Rad). It should be noted
that the gelatinolytic activity detected by this technique results
from the presence of active MMPs, their inactive pro-enzymes
and MMP-TIMP complexes (which are partly dissociated by
SDS) [39].
Gelatinolytic activity in CDLs treated with galardin. To
further assess the role of MMPs in CDL mutability, tissues in
the different mechanical states were incubated with galardin. As
there is considerable variability between individuals, we used
two animals each for the uninhibited and galardin-inhibited
conditions per gel. Per analysis, 10 CDLs (5 CDLs of each
animal) were used for the uninhibited and inhibited conditions.
More than five animals were used for each mechanical state.
For the standard state, samples were maintained in a solution of
50 mM galardin in SW; stiff CDLs were kept in a solution of
50 mM galardin in AChSW; and compliant tissues were
incubated with 50 mM galardin in PPSW. Control CDLs (from
at least 5 animals per mechanical state) were left in SW,
AChSW or PPSW alone. After overnight incubation at 4uC,
tissues were prepared to measure their gelatinolytic activity as
previously described in section 2.3.1. Overnight incubation with
galardin was employed, because in an initial trial incubation for
10 min resulted in no discernible change in gelatinolytic activity.
This appears to be at odds with the rapid effect of galardin on
the mechanical properties of CDLs, as described below, but
indicates that, to become enzymographically detectable, inhibi-
tion of MMP activity sufficient to affect CDL tensility may
require amplification such as was afforded by the prolonged
galardin treatment.
Ethical Treatment of Animals
No specific permits were required for the described field studies
since sea-urchins (Paracentrotus lividus) are invertebrates. This work
was performed with a species that is not endangered or protected.
The location of the field studies is also not privately owned or
protected in any way.
Statistical Analysis
All experiments were repeated at least five times. Statistical
differences between CDLs in different functional states were
Metalloproteinases in Mutable Sea Urchin Ligament
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determined using Kruskal-Wallis one-way analysis of variance
with Dunn’s post-hoc test. All statistics were performed using
GraphPad Prism 5 Demo software (version 5.02). Data are given
as mean 6 standard deviation (SD). Results were considered
statistically significant when P,0.05.
Results
Mechanical Properties
Viscoelasticy of CDLs in different mechanical
states. Before evaluating the viscoelasticity of CDLs in the
different mechanical states, the relationship between the maxi-
mum strain imposed on cyclically (constant frequency 1 Hz)
loaded CDLs in different mechanical states and the resulting
maximum stress was investigated (Fig.2A).
As is typical for collagenous tissues, the stress-strain curves were
J-shaped, with a non-linear toe and heel region followed by a
linear (constant stiffness) region, indicating that CDLs were more
compliant at low strains and became stiffer as deformation
progressed. This transition was abrupt and took place at 10%
deformation. Fig. 2B shows the relationship between the cyclical
loading frequency at a constant maximum strain of 13% and the
complex modulus (E*) of CDLs in the three mechanical states. On
the basis of these results, it was decided that a maximum strain of
13% and a loading frequency of 1 Hz should be employed in
subsequent experiments.
In tests with CDLs in the standard state, the replacement of SW
with PPSW resulted in a decrease in the complex modulus, which
was partly reversible and repeatable (Fig. 3A, C, Table 1).
In equivalent tests in which SW was replaced with AChSW,
there was a reversible and repeatable increase in the complex
modulus (Fig. 3B, C, Table 1).
In the present investigation, there was a high level of variation
in the mechanical results generated by DMA, which is reminiscent
of the inter-individual variability that has previously been reported
in MCTs of P. lividus and other echinoderms [40,41]. To
compensate for this effect, which could have masked the influence
of chemical agents on CDL mechanical behavior, for each
mechanical condition (compliant, standard and stiff) we used five
animals, and a minimum of three CDLs from each animal, one for
each mechanical condition.
Effect of MMP inhibition on CDL viscoelasticity. When
galardin was applied to standard CDLs, there was some instability
due to addition of the solution, and then the stiffness (E*) increased
quite rapidly to a maximum value, after which it decreased
gradually, with E* returning, after up to 18 min, to roughly the
value observed at the beginning of the test (Fig. 4A, B). The effect
of MMP inhibition appeared to be concentration-dependent, the
higher concentration of galardin (50 mM) producing both a higher
(though not statistically significant) mean maximum E* and a
longer mean response duration (which was statistically significant)
in standard CDLs (Fig. 4A–D). Therefore the higher concentra-
tion was selected and used in further experiments with CDLs in
the different mechanical states. As in standard CDLs, the MMP
inhibitor enhanced rapidly the stiffness of compliant and stiff
CDLs, which then decreased gradually to initial values (Fig. 5A).
The increase in E* caused by galardin was significantly greater
in standard CDLs (mean fold of increase 1.5760.38; N = 5) than
in stiff CDLs (mean fold of increase 1.0960.06; N = 5); the
increase in E* of compliant CDLs (mean fold of increase1.560.47;
N = 5) did not differ significantly from the other two (Fig. 5A).
Increases in the storage modulus showed exactly the same pattern,
while increases in the loss modulus and tan d did not vary
significantly between the three mechanical states (Fig. 5B–D). The
increase in the E* of standard CDLs caused by galardin was not
significantly different from that observed when standard CDLs
were stimulated with AChSW (mean fold of increase 2.1960.86;
N = 5).
As the mutability phenomenon is reversible, further tests were
performed in order to determine if the effect of the MMP inhibitor
was reversible. The reversibility of the inhibitory effect of 50 mM
galardin on standard, stiff and compliant CDLs was demonstrated
by rinsing CDLs with sea water (SW), acetylcholine chloride in sea
water (AChSW) or propylene phenoxetol in sea water (PPSW),
respectively, after exposure to galardin (Fig. 6A–C). The inhibitory
effect was reversible and could be subsequently repeated. Although
in all three mechanical states the mean normalized stiffness of the
second treatment was lower than that of the first, these differences
were not significant (Fig. 6D).
Gelatinolytic Activity of CDLs in Different Mechanical
States and the Effect of Galardin
A similar pattern of gelatinolytic bands with molecular weights
ranging from 35 to 250 kDa was obtained for standard, compliant
and stiff states (Fig. 7A, B, E). Stiff CDLs had clearly the highest
level of gelatinolytic activity in all five zymograms (Fig. 7A, B), and
densitometric analysis showed that there was a progressive
increase in total gelatinolytic activity from the compliant to the
stiff states (Fig. 7C). Where the resolution of the bands was high
enough (Fig.7B), densitometric analysis indicated that the
Figure 2. Mechanical properties of CDL. (A) Representative stress vs. strain curves of CDLs from one animal in the three mechanical states. (B)
Effect of frequency on the complex modulus of CDLs from one animal in the three mechanical states tested at 13% strain.
doi:10.1371/journal.pone.0049016.g002
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gelatinolytic activity of stiff CDLs was higher than that of standard
and compliant CDLs at all molecular weights, the difference being
particularly great at molecular weights above 53 kDa (up to six
times higher in the example shown in Fig. 7B). This, however,
could not be confirmed in all cases.
Overnight treatment of CDLs with 50 mM galardin had little
effect on the mean normalized gelatinolytic activity of stiff CDLs,
but caused a pronounced and statistically significant reduction in
that activity of the standard CDLs, and caused a pronounced,
although not statistically significant, reduction in that activity of
the compliant CDLs (Fig.7 D, E).
Discussion
Basic Organization and Mechanical Properties of CDLs
The biomechanical behavior of the CDL is dependent on the
composition and organization of its extracellular components. The
CDL consists of parallel aggregates of collagen fibrils to which
proteoglycans are attached, potentially serving as binding sites for
molecules responsible for interfibrillar cohesion [2,5,19]. Available
evidence suggests that interfibrillar cohesion is mediated by
complexes of molecules, some constitutive and others regulatory
[2,19–21,42]. The collagen fibril bundles (‘fibers’) provide the
ECM with mechanical integrity and strength, and are delimited by
a network of fibrillin-containing microfibrils, which is an elastic
component that may provide resilience and help the CDL to re-
shorten after elongation [2,5,11,12]. As for other mutable
collagenous structures, the mechanical adaptability of the CDL
depends on the modulation of interfibrillar cohesion and not on
changes in the organization or mechanical properties of the
collagen fibrils [5,36]. There is evidence that the juxtaligamental
cells (JLCs) control this process in the CDLs and other MCTs
[2,36].
Effect of MMP Inhibition on CDL Viscoelasticity
During the development, growth and remodelling of load-
bearing connective tissues in mammals, fibrillar collagens are
secreted and continuously degraded by MMPs [23–25]. It is
notable that the sea urchin genome includes at least 26 MMP
Table 1. Mean values 6 S.D. of unnormalized complex modulus (n = 7).
Mean Complex Modulus before
ACh stimulation (MPa)
Mean Complex Modulus after
ACh stimulation (MPa)
Mean Complex Modulus before
PPSW stimulation (MPa)
Mean Complex Modulus after PPSW
stimulation (MPa)
12.6612.23 20.3469.17 22.8613.8 16.74612.31
doi:10.1371/journal.pone.0049016.t001
Figure 3. Effects of propylene phenoxetol (PPSW) and acetylcholine (AChSW) on the mechanical properties of the CDL. (A)
Immediate effect of PPSW on a standard CDL. (B) Immediate effect of AChSW on a standard CDL. (C) Comparison of the normalized complex modulus
of compliant (PPSW-treated), standard (untreated) and stiff (AChSW-treated) CDLs (n = 7).
doi:10.1371/journal.pone.0049016.g003
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genes with significant similarity to those of mammals [43,44]. If
MMPs have a role in the variable tensility of MCTs, they are likely
to contribute to MCT destiffening by hydrolyzing components of the
interfibrillar crosslink complexes and therefore their inhibition
should reverse and/or block destiffening.
The MMP inhibitor used in this investigation was galardin, or
GM6001, which is highly potent against mammalian MMP-1, -2, -
3, -8 and -9. It has a collagen-like backbone, to facilitate binding to
the active site of MMPs, and a hydroxamate structure, which
chelates the zinc ion located in the catalytic domain of MMPs [45–
50]. Such chelation results in alteration of the attached MMP
molecular conformation, blocking its proteolytic activity against
extracellular matrix components and other substrates [45–50].
The involvement of MMPs in CDL mutability was supported by
our finding that galardin (50 mM) increased the stiffness (E*) and
storage modulus (E) of CDLs in all three mechanical states,
although it had a significantly lower effect on stiff CDLs. The
preferential enhancement of the storage modulus and lack of effect
on the loss modulus indicates that externally applied force was
transferred more efficiently to the stiff and inextensible collagen
fibrils, which would be a consequence of the strengthening of
interfibrillar cohesion. The involvement of MMPs in CDL
mutability was also suggested by the observations that (1) the
increase in E* of standard CDLs following galardin treatment was
not significantly different from that observed when standard CDLs
were treated with AChSW and (2) that, as is the case for in vivo
changes in mechanical properties, the action of the MMP inhibitor
was reversible.
In response to galardin, CDL stiffness increased to a maximum
and then returned to pre-treatment values after up to 18 min
(though the duration of the responses was very variable). The
reason for the transient nature of galardin’s effect is unclear. As
available evidence indicates that galardin retains its MMP-
inhibitory action in experimental solutions for at least days [48],
it is likely that the transiency is due to the CDLs themselves. The
progressive reduction in stiffness shown by some CDLs before any
agent was added (see e.g. Fig. 6 B, C) suggests that the protracted
oscillatory stress to which the CDLs were subjected could by itself
cause interfibrillar slippage, and it is possible that this over-
whelmed the galardin-induced increase in crosslink density after
variable periods of time. It may also be relevant that the galardin
concentrations employed in the experiment were very low, 50 mM
being ‘‘therapeutically attainable’’ [48]. It is also possible that the
galardin-induced responses, their transiency and their variability
Figure 4. Effect of MMP inhibition. (A) Effect of 25 mM galardin on a standard CDL. (B) Effect of 50 mM galardin on a standard CDL. (C)
Comparison of the effects of different galardin concentrations. Values were normalized against E* values obtained before galardin addition. (D)
Comparison for different galardin concentrations of the time period between the addition of galardin and the return of E* to the pre-treatment value.
The action of galardin was quantified by normalizing the maximum E* reached after galardin addition against the value just before the application of
the chemical.
doi:10.1371/journal.pone.0049016.g004
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result partly from the inhibition of MMP effects on cellular rather
than extracellular components of the CDLs. There is, for example,
evidence that certain MMPs can inactivate calcium channels in
mammalian vascular smooth muscle [49]. Specific experimenta-
tion would be required, however, to elucidate any involvement of
such a mechanism in the regulation of CDL tensility.
If MMPs contribute to the mutability of the CDL and of MCTs
in general, their primary role could be reactive or constitutive:
either it is only when the tissue is destiffening that activated MMPs
are present in the extracellular environment and degrade their
substrates, or activated MMPs are continuously present in the
extracellular environment, and what varies is the extent to which
the enzymes are inhibited, less inhibition resulting in destiffening
and more inhibition resulting in stiffening. We found that galardin
stiffened CDLs in all three mechanical states, implying that in all
three states there is (1) ongoing MMP activity, which thus supports
the constitutive model, and (2) ongoing production of crosslink
components. The significantly weaker effect of galardin on stiff
CDLs than on standard or compliant CDLs would be expected,
since in stiff CDLs MMP activity would already be greatly
suppressed, together with the obvious fact that stiff CDLs must
have much less capacity to stiffen further than standard and
compliant CDLs. The constitutive model is illustrated in Fig. 8
(which is another ‘‘three-state’’ model: see Motokawa and Tsuchi,
2003) [51]. We hypothesize that the stiffness of the CDL is
adjusted through the modulation of constitutive MMP activity.
Since in the collagenous tissues of other animals, activated MMPs
are constrained mainly by enzyme inhibitors, such as TIMPs
[39,52,53] we further hypothesize that the control of CDL stiffness
depends ultimately on the rate of release into the extracellular
environment of endogenous MMP-inhibitors.
One aspect of our results that still requires explanation is the
insignificant difference between the effects of galardin on CDLs in
the compliant and standard states. At the moment we can only
Figure 5. Effect of MMP inhibition on CDL viscoelasticity. (A) complex modulus, (B) storage modulus, (C) loss modulus and (D) tan delta of
compliant, standard and stiff CDLs treated with 50 mM galardin in PPSW, SW, and AChSW respectively. The action of galardin was quantified by
normalizing the maximum E* reached after galardin addition against the value just before the application of the chemical. The asterisk (*) represents
statistically significant difference P,0.05 and the double asterisk (**) P,0.01.
doi:10.1371/journal.pone.0049016.g005
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speculate that this relates to an asymmetry in the changes in MMP
activity responsible for the compliant to standard and standard to
stiff shifts, i.e. the increase in crosslink density associated with the
compliant to standard shift, and the corresponding degree of
MMP inhibition, may be much less (and perhaps too low to be
detected by enzyme zymography) than the increase in crosslink
density and degree of MMP inhibition that bring about the
standard to stiff shift. It is also possible that the compliant to
standard shift relies mainly on a mechanism other than MMP
inhibition. It appears that different mechanisms are responsible for
the compliant to standard and standard to stiff changes occurring
in holothurian dermis [21].
Gelatinolytic Activity of CDLs in Different Mechanical
States and the Effect of Galardin
MMPs have a wide spectrum of activities: in particular, they
degrade all extracellular matrix components, as well as growth
factors, pro- and anti-inflammatory cytokines and chemokines,
and they also modify apoptotic signals and regulate the immune
response. As a consequence, they play a fundamental role in tissue
morphogenesis, wound healing, tissue repair and remodeling, and
in the progression of some diseases such as cancer [22–25,31].
Included amongst the potential substrates of some MMPs is
gelatin, i.e. collagen that has been denatured in the first stage of
the degradation process [24,39,52]. We analyzed the gelatinolytic
activity and distribution pattern of CDLs in different mechanical
conditions using gelatin-zymography. This detects the presence of
activated MMPs, inactive pro-MMPs and some MMPs previously
bound to TIMPs [39]. No qualitative differences in the general
pattern of gelatinolytic activity were observed between standard,
stiff and compliant conditions. There were, however, significant
quantitative differences, with a progressive increase in total
gelatinolytic activity in the compliant, standard and stiff states
(Fig. 7A–C). The absence of a P. lividus protein database and
differences between the proteolytic patterns of the CDL and
mammalian tissues prevented identification of the distinct enzy-
matic bands, although comparison with the gel of a human cell
Figure 6. Reversibility of MMP inhibition. (A–C) Examples of recordings showing the reversibility of the galardin effect on (A) standard, (B) stiff
and (C) compliant CDLs. (D) Normalized results. Tissues in compliant, standard and stiff states were stimulated with 50 mM galardin, washed and
treated again with galardin. Data are expressed as means 6 SD.
doi:10.1371/journal.pone.0049016.g006
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line suggested that mammalian MMP-2-like and MMP-9-like
enzymes were not present.
It appeared that the higher gelatinolytic activity of stiff CDLs
was particularly prominent at higher molecular weights, which
probably resulted from the presence of MMP-MMP complexes
and MMPs bound to endogenous inhibitors [39].The presence of
MMP-MMP and MMP-TIMP complexes is associated with the
inactivation and removal of MMPs, the latter occurring at least
partly by endocytosis [39,52]. This positive correlation between
degree of stiffness (compliant,standard,stiff) and increasing
levels of higher molecular weight complexes (resulting from
increasing inhibition of activated MMPs) is consistent with our
model (Fig. 8). More difficult to reconcile with this model is the
apparent positive correlation between degree of stiffness and the
total gelatinolytic activity (Fig. 7C), which seems to be the opposite
of what would be expected if MMPs cause destiffening. However,
it has to be stressed again that gelatinolytic activity results from the
presence of not only active MMPs, but also of their inactive pro-
enzymes and the molecular complexes associated with the removal
and degradation of MMPs (i.e. MMP-TIMP and MMP-MMP
complexes) [39]. It is possible that in the standard and stiff states,
in which there is increasing inhibition of MMPs, there is a
Figure 7. MMPs of CDLs in compliant, standard and stiff conditions visualized by gelatin zymography. (A) Zymogram showing pro-
enzyme and active MMP band profile of CDLs in the three mechanical states. (B) Zymogram comparing the band profiles of CDLs, compared with
human cell line showing MMP-2 and MMP-9 activity; this zymogram was included because of its very good band separation. (C) Optical density of
MMP activity in CDLs in the three mechanical states. (D) Comparative densitometric analysis of scanned gels of CDLs in the different mechanical
states with and without 50 mM galardin. Data are expressed as means 6 SD. The asterisk (*) represents statistically significant difference P,0.05.
MMPs were detected in more than six animals for each of the three mechanical states. (E) Zymogram comparing standard CDLs with and without
galardin treatment.
doi:10.1371/journal.pone.0049016.g007
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Figure 8. Hypothetical model of the involvement of MMPs in MCT mutability. It is known that MCTs consist of discontinuous collagen
fibrils crosslinked by complexes of molecular components, and that changes in the mechanical properties of MCTs result from rapid changes in the
strength of the interfibrillar cohesion that is mediated by these crosslink complexes. We found that the synthetic MMP inhibitor, galardin, increased
the stiffness of CDLs in all three mechanical states, which suggests that in all three states there is ongoing MMP activity that has the potential to
degrade components already incorporated into existing crosslink complexes and components that have been secreted but not yet incorporated, and
ongoing synthesis and release of new crosslink components. The model acknowledges that MMPs are synthesized and secreted as inactive pro-
enzymes, then activated extracellularly by proteolytic removal of the pro-peptide domain [39,51,52]. It is envisaged that crosslink components are
synthesized and secreted separately, then assembled extracellularly to form functional complexes. The black boxes represent cells, although it should
be noted that the three processes do not necessarily occur in different cell-types. The red box represents the process by which MMP-TIMP complexes
are removed and degraded. For the sake of simplicity, the model assumes that activated MMPs and new crosslink components reach the extracellular
environment at a constant rate. It is hypothesized that interfibrillar cohesion is regulated only through changes in the rate at which an endogenous
MMP inhibitor (which we assume is a TIMP-like molecule) is released into the extracellular environment. In the stiff state there are high levels of TIMP
secretion (1), MMP inhibition and crosslinking. In the standard state there are intermediate levels of TIMP secretion (2), MMP inhibition and
crosslinking. In the compliant state there are low levels of TIMP secretion (3), MMP inhibition and crosslinking. Also represented is the possibility that
an endogenous inhibitor could function as a component of the crosslink complex (red arrows) and thus have a dual function (which may apply to
TIMP-like tensilin). The model also assumes that the production of MMP-TIMP complexes exceeds the rate of removal and degradation of MMP-TIMP
complexes, which would account for the positive correlation between degree of CDL stiffness and total gelatinolytic activity. The components
marked with a red asterisk contribute to the gelatinolytic activity of CDLs as quantified by gelatin zymography.
doi:10.1371/journal.pone.0049016.g008
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progressive accumulation of MMP-TIMP and MMP-MMP
complexes in the extracellular environment, perhaps because the
rate of production of these ‘‘disposal complexes’’ exceeds their rate
of removal and degradation (Fig. 8).
The effects of galardin on the gelatinolytic activity of the CDLs
provide further support for the model illustrated in Fig. 8.
Galardin did not affect the gelatinolytic activity of stiff CDLs,
which is expected, since, according to our model, MMP activity of
stiff CDLs would already be maximally inhibited. Our model
predicts that in both the standard and compliant states there
should be significant MMP activity, and in accordance with this
we found that galardin significantly reduced the total gelatinolytic
activity of standard CDLs, although its effect on compliant CDLs
was marked but not statistically significant.
As discussed in connection with the similar pattern of effects of
galardin on the mechanical properties of the CDL, the lack of
differentiation between the gelatinolytic activities of compliant and
standard CDLs after galardin treatment may be due to an
asymmetry in the changes in crosslink density and MMP inhibition
associated with the compliant to standard and standard to stiff
shifts, or because MMP inhibition is not involved in the compliant
to standard shift.
Identity of the Endogenous Inhibitor
According to our hypothesis, the stiffness of the CDL and other
echinoderm MCTs is determined by the rate of secretion of one or
more endogenous MMP inhibitors. It may of course be relevant
that tensilin – a possible regulatory protein from MCT that has
been fully sequenced – shows homologies to mammalian TIMPs.
Holothurian tensilin aggregates collagen fibrils and stiffens samples
of whole dermis. It is stored intracellularly and has been
immunolocalized to the intracellular granules of juxtaligamental-
like cells in holothurian dermis [19]. Whilst it is the role of tensilin
as a potential regulatory stiffening agent that has been empha-
sized, it is notable that it cannot induce maximal stiffening
(equivalent to the standard to stiff shift) of holothurian dermis,
though another incompletely characterized protein can do this
[20,21]. Furthermore, the homology of tensilin’s deduced peptide
sequence to mammalian TIMPs is stronger in its N-terminal
domain [19], which in mammalian TIMPs forms the unit that
inhibits MMPs [51,52]. It is therefore possible that tensilin retains
the capacity to inhibit MMPs and even that this is its main
function. Like mammalian TIMP-3, tensilin binds to the sulphated
GAGs of ECM components through its C-terminal domain [19],
which suggests that tensilin may be a TIMP that has evolved the
additional capacity to act as an adjuvant stiffener. We therefore
suggest in our model (Fig. 8) that the endogenous regulatory
inhibitors are TIMPs that may also contribute to crosslink
complexes.
Comparison with the Uterine Cervix
The mammalian uterine cervix can be regarded as another
example of a mutable collagenous structure that demonstrates
reversible changes in stiffness. Its mutability differs from that of
echinoderm MCTs in its longer time course, among other aspects.
It occurs in three stages: cervical ‘ripening’ begins about four
weeks before birth and results in expansion of the cervical canal to
3–4 cm, followed by cervical dilatation to 10 cm during parturi-
tion itself, which occurs within hours, and then by the recovery of
cervical stiffness, which takes days. These changes in mechanical
properties result from modification of the biochemical composition
and structure of the cervix and by MMP-dependent degradation
of collagen fibrils and other ECM components. The MMP activity
is modulated by endogenous inhibitors, including TIMPs, which
become particularly important as a brake on the degradation
process at the end of parturition [31,34,54]. The involvement of
MMPs in cervical destiffening is reactive: the increase in MMP
activity results from a dramatic rise in MMP concentrations
following increased synthesis by neutrophilic leukocytes, and is
under mainly endocrine control [31,54]. Thus regulation of
MMPs at the transcriptional level is an important component of
the cervical mutability phenomenon. In contrast to this, we
postulate that in echinoderm MCTs the regulation of MMP
activity occurs mainly at the extracellular level and is determined
by the rate of inhibitor secretion. This provides a much faster
responsiveness (within timescales of,1 s to minutes) than could a
mechanism dependent on the adjustment of protein synthesis and
is amenable to nervous control, which allows changes in the
mechanical state of MCTs to be coordinated with the activity of
contractile systems.
We believe that Fig. 8 illustrates the simplest model that can
integrate our results with information derived from other MCTs.
Aspects of it are admittedly speculative, but these are testable by
further experimentation. The uniqueness of echinoderm MCT
cannot be exaggerated: collagenous connective tissue that is
directly innervated by the motor nervous system, and that can
alter drastically and reversibly its mechanical properties within
short physiological timescales, appears to have evolved only in the
phylum Echinodermata (though a ‘‘pre-neural’’ version of the
phenomenon occurs in the Porifera [55]). Despite this restricted
taxonomic distribution, the investigation of MCT has the potential
to provide information of widespread biomedical applicability
[2,56].
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